Blog

qordata thought leaders and subject matter experts share their insights and experiences

Zafar Ahmed
Written By
Zafar Ahmed
August 16, 2017
0 Comments

As day two of the 11th Annual Forum on Transparency & Aggregate Spend wrapped up, I thought I’d quickly summarize what I learnt during a session by CMS’ Director, Division of Data and Informatics, Robin Usi, on planned CMS enhancements. Big Picture Changes Aided by analytics, we’ve already demonstrated how managing an ever-growing volume of datasets can be problematic for pharmaceutical companies. That’s why one of the first enhancements—an emphasis on efficiency by the CMS—comes as good news. This summer, a helpdesk customer service representative interface has been introduced to further improve responsiveness. Paired with infrastructure upgrades and administrative improvements, reporting entities (yes, medical drug and device manufacturers, we mean you), can expect better turnaround time, swifter resolution and query […]

Elizabeth Bodine
Written By
Elizabeth Bodine
July 27, 2017
0 Comments

“Not knowing what is in my data.” “I don’t know how others interpret the CMS data I have submitted.” “Have I been comprehensive enough? I can never be sure.” These are some responses organizations specializing in pharma-compliance via data analytics receive from compliance/transparency professionals when they ask: “What Keeps You Up At Night?” And for pharmaceutical professionals not using a robust spend analytics platform, there’s plenty of sleep to be lost. Fortunately, there’s an easy solution to avert the stress associated with CMS Submission. And that is: Knowing how to leverage data. Because of the sheer volume of records entered into the CMS Database each year, (40.77 million records, on 30th June 2017), it is difficult for an organization to […]

Ned Mumtaz
Written By
Ned Mumtaz
July 26, 2017
0 Comments

This blog follows from Part I, where we shared advice from Compliance/Transparency professionals from Shire Pharmaceuticals, Porzio Bromberg and Merz North America on how to make your datasets more robust and CMS compliant. Treat Your Data Like Someone At The CMS Or DOJ Would: Compliance teams often focus on the supply side of spend data, i.e. presentation of their individual submissions. What recedes to the backburner in such cases is the extent of scrutiny, the search for common data culprits (e.g. missing NPIs) and the questionable records that interest authorities in CMS and the DoJ. Establish a habit of treating your data to the same scrutiny regulators would. Don’t assume that just because your numbers make sense internally, they will […]

Ned Mumtaz
Written By
Ned Mumtaz
July 25, 2017
0 Comments

In our most recent webinar, we explored how data management processes differ in pharmaceuticals across USA. Interestingly, processes are standardized across the most compliant and transparent medical drug and device manufacturers. Based on this, we must ask: Is there one best way of going managing and leveraging spend analytics data? Yes, accounting for differences brought in by internal policy. The processes described by our panelists, April Pierce, Chrissy Bradshaw and Elizabeth Bodine from Shire Pharmaceuticals, Porzio Bromberg, and Merz North America, respectively, had quite a few steps in common: Information Sharing Must Be Proactive: This is important. Your audience, according to Elizabeth Bodine, need to know what they’re looking for. It could be performance figures, information related to KOL or […]

Upcoming Event

Life Sciences GDPR Bootcamp

14 Nov to 14 Nov, 2017
10:00 am To 6:00 pm BST
DETAILS

Ask an Expert

Get all the insights, and the answers to the most critical issues in pharma compliance from thought leaders in qorcommunity

Get Answer
OUR SOLUTIONS CAN SIMPLIFY YOUR COMPLIANCE EFFORTS.